• Phase 3 Data on CCH for Cellulite

    26 days ago - By Surgical Aesthetics Magazine

    Endo International announced positive results from two Phase 3 RELEASE studies of collagenase clostridium histolyticum for the treatment of cellulite in the buttocks. Subjects receiving CCH showed highly statistically significant levels of improvement in the appearance of cellulite with treatment, as measured by the trial's primary endpoint, which was at least a two-level composite improvement in cellulite severity in the target buttock at Day 71. In addition, RELEASE-1 passed eight out of eight key secondary endpoints and RELEASE-2 passed seven out of eight key secondary...
    Read more ...